A Blinded-Initiation Study of Medication Satisfaction in Subjects With Schizophrenia Treated With Paliperidone ER [extended release] After Suboptimal Response to Oral Risperidone.

Trial Profile

A Blinded-Initiation Study of Medication Satisfaction in Subjects With Schizophrenia Treated With Paliperidone ER [extended release] After Suboptimal Response to Oral Risperidone.

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Feb 2017

At a glance

  • Drugs Paliperidone (Primary) ; Risperidone
  • Indications Schizophrenia
  • Focus Therapeutic Use
  • Sponsors Janssen Research & Development
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 20 Jun 2012 Planned number of patients changed from 132 to 150 as reported by European Clinical Trials Database.
    • 06 Mar 2010 Results published in International Clinical Psychopharmacology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top